Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fen Xue
Observed name:
薛 芬
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
ORCID:
0009-0002-3361-1206
Observed ORCID:
0009-0002-3361-1206
OpenAlex ID:
A5100585417
Long-term Patterns of Regional Failure for Nasopharyngeal Carcinoma following Intensity-Modulated Radiation Therapy
2017
·
Fen Xue
, Chaosu Hu
, et al.
·
Journal of Cancer
·
29
PDF
Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinoma
2017
·
Fen Xue
, Chaosu Hu
, et al.
·
OncoTargets and Therapy
·
23
PDF
Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era
2022
·
Xiaoshuang Niu
, Fen Xue
, et al.
·
International Journal of Medical Sciences
·
19
PDF
Long-term results of the phase II dose and volume de-escalation trial for locoregionally advanced nasopharyngeal carcinoma
2022
·
Fen Xue
, Dan Ou
, et al.
·
Oral Oncology
·
17
Prognostic value of post-radiotherapy neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal carcinoma
2019
·
Dan Ou
, Xiaoshen Wang
, et al.
·
Strahlentherapie und Onkologie
·
15
Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
2021
·
Xiaoshuang Niu
, Fen Xue
, et al.
·
Translational Oncology
·
14
PDF
Epstein–Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review
2020
·
Fen Xue
, Xiayun He
·
Methods in molecular biology
·
13
Sequential vs Induction Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial
2025
·
Fen Xue
, Dan Ou
, et al.
·
JAMA Oncology
·
12
Prognostic efficacy of extensive invasion of primary tumor volume for T3-4 nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
2019
·
Fen Xue
, Dan Ou
, et al.
·
Oral Oncology
·
12
Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy
2017
·
Fen Xue
, Chao-Su Hu
, et al.
·
癌症:英文版
·
12
PDF
Neoadjuvant famitinib and camrelizumab, a new combined therapy allowing surgical resection of the primary site for anaplastic thyroid carcinoma
2022
·
Shuwen Yang
, Dongmei Ji
, et al.
·
Cancer Reports
·
11
Local regression and control of T1‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
2018
·
Fen Xue
, Dan Ou
, et al.
·
Cancer Medicine
·
11
PDF
Impact of minimum point dose on local control and toxicity in T3–4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy
2017
·
Fen Xue
, Chaosu Hu
, et al.
·
Japanese Journal of Clinical Oncology
·
10
Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma
2016
·
Fen Xue
, Duanshu Li
, et al.
·
Oncotarget
·
8
PDF
Is nasopharyngeal carcinoma in young patients a distinct clinical entity? A single-institution case matched analysis in the era of intensity-modulated radiotherapy
2020
·
Dan Ou
, Xiaoshen Wang
, et al.
·
Oral Oncology
·
5
Comparing long-term efficacy and safety of GP versus TPF sequential chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
2024
·
Ying Zhu
, Fen Xue
·
BMC Cancer
·
4
PDF
Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era
2024
·
Yuming Zheng
, Fen Xue
, et al.
·
Cancer Medicine
·
4
PDF
Pretreatment FDG PET in prognosis of locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
2025
·
Xiaoshuang Niu
, Fen Xue
, et al.
·
International Journal of Medical Sciences
·
3
PDF
Clinical outcomes and prognostic factors of stereotactic body radiation therapy in metastatic nasopharyngeal carcinoma
2025
·
Ying Zhu
, Fen Xue
·
Therapeutic Advances in Medical Oncology
·
3
Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
2022
·
Fen Xue
, Xiaoshuang Niu
, et al.
·
Frontiers in Oncology
·
3
PDF
Prognostic value of early Epstein-Barr Virus DNA response in patients with locoregionally advanced nasopharyngeal carcinoma
2026
·
Chengrun Du
, Ruiping Zhai
, et al.
·
Oral Oncology
·
2
Long-term results of locoregionally advanced nasopharyngeal carcinoma treated with cisplatin and 5-fluorouracil induction chemotherapy with or without docetaxel in young and middle aged adults
2025
·
Yuming Zheng
, Fen Xue
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
2
Impact of Paranasal Sinus Invasion on Oncologic and Dosimetric Outcomes in Nasopharyngeal Carcinoma Following Intensity-Modulated Radiation Therapy—Implications for Risk Stratification and Planning Optimization
2020
·
Xin Zhou
, Xiayun He
, et al.
·
Frontiers in Oncology
·
2
PDF
DNA methylation-mediated silencing of MEOX1 promotes glycolysis and immune evasion in colorectal cancer cells through inhibition of GLP2R transcription
2026
·
Dingkong Liang
, Fen Xue
, et al.
·
Cell & Bioscience
·
1
PDF
Sequential chemoradiotherapy versus induction chemotherapy plus concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicentre, open-label, non-inferiority, randomised, phase 3 trial.
2024
·
Chao-su Hu
, Fen Xue
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Show more works
View as search
Works count:
28
Citation count:
236
H-index:
11
I10-index:
13
Year
Topic
Type